Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Stock-Based Compensation (Details 3)

v3.20.2
Stockholders' Equity and Stock-Based Compensation (Details 3)
6 Months Ended
Jun. 30, 2020
$ / shares
shares
Stockholders' Equity  
Shares, non-vested, beginning | shares 84,873
Shares, Granted | shares
Shares, vested | shares
Shares, Forfeited | shares (1,229)
Shares, non-vested, end of period | shares 83,644
Weighted average exercise price, Beginning $ 10.73
Weighted average exercise price, granted 0.00
Weighted average exercise price, vested 0.00
Weighted average exercise price, forfeited 10.80
Weighted average exercise price, end of period 10.73
Weighted average fair value grant date, beginning 5.15
Weighted average fair value grant date, granted 0.00
Weighted average fair value grant date, vested 0.00
Weighted average fair value grant date, forfeited 8.33
Weighted average fair value grant date, end of period $ 5.10